Dr. Aplenc investigates ways to improve the outcomes of children with cancer, particularly acute myeloid leukemia, with clinical epidemiology studies and translational research.

Leading the negotiation of industry-sponsored research agreements, as well as those concerning the sharing of data, materials, and other information with academic and industry partners.

Provides leadership in compliance and customer service for pre-award and non-financial post-award administration by assisting in developing and submitting proposals, serving as a resource for sponsor policies and regulations, and issuing and negotiating incoming and outgoing subawards and outgoing consulting agreements.

Karen Burke leads the Office of Research Compliance (ORC) and works closely with other relevant offices in the Research Institute to develop, maintain, and enhance the integrity of the program.

Daniel Colbert leads the Clinical Research Contracts Administration team responsible for the negotiation and execution of industry-sponsored clinical trial agreements.

Ensures ethical and efficient compliance with terms and conditions during the post-award grant phase, including implementing the grant, reporting progress, and completing closeout requirements.

Dr. Davidson works to understand the molecular basis of childhood onset neurodegenerative diseases and the development of gene and small molecule therapies for treatment. She also focuses on how noncoding RNAs participate in neural development and neurodegenerative disease processes, and how they can be harnessed for therapies.

In conjunction with research senior leadership, leads the operation, identification, growth, and development of the physical infrastructure required to support Children’s Hospital of Philadelphia Research Institute.

Jessi Erlichman possesses a deep level of institutional knowledge and leverages this asset to help research teams create solutions and promote partnerships.

Dr. Ferro is a clinical informatician, pediatrician, researcher, and strategic systems thinker dedicated to demonstrably better outcomes for patients, families, and healthcare teams. She is course director for the informatics & quality improvement rotation in the Clinical Informatics Fellowship and co-leads CHOP's Innovation Ecosystem.

Dr. Furth's research focuses on defining risk factors for kidney disease progression in children; characterizing the effect of kidney function decline on neurodevelopment, cognitive abilities and behavior; identifying the prevalence and evolution of cardiovascular disease risk factors, and examining the effects of declining glomerular filtration rate on children’s growth.

Establishes a set of definitions, policies, and procedures to guide the involvement of individuals such as long-term collaborators, high school and college-level students, graduate students, and others who are not regular CHOP employees in the Research Institute’s programs.

Drives value by combining in-depth knowledge of project and program management, training in waterfall and agile methodologies, knowledge of a variety of business functions, and strong leadership and team building skills.

Alexander Gonzalez leads the DBHi Translational Research Informatics Group (TRiG), a team of data integration analysts and data scientists specializing in data integration solutions designed to manage complex rare disease data in biomedical research.

Dr. Heather Griffis leads a team of data managers, scientists, and methodologists who work with investigators to merge, clean, and structure data; provide analytic datasets; and apply appropriate methods to various data sources, in order to answer research questions that inform practice and policy.

Developing and implementing strategy to lead the operations of the research-related regulatory, compliance, and safety programs across all types of research including human, animal, and laboratory-based research.

Dr. Jolly-Tornetta's role involves protecting and commercializing innovations developed out of Children's Hospital of Philadelphia by evaluating the commercial viability of CHOP technology, developing strategies for the protection of related intellectual property, and overseeing the drafting, negotiation, and execution of commercialization transactions.

Nick Kight facilitates seamless interactions with CHOP Research Information Systems (RIS) by promoting knowledge, accessibility, and user-friendly request and support methods for RIS applications and services.

Leads and evolves the technology and support services provided by Research Information Services to the Research Institute.

Directly overseeing several Research Administration departments that support investigators in their day-to-day needs, while looking for ways to enhance teamwork and collaboration.

Dr. Luberti leads DBHi's informatics education program as medical director, where he helped develop a robust array of seminar and educational series, curriculum-focused informatics initiatives, and collaborations with informatics programs throughout the Philadelphia area and beyond.

Advances the Research Institute’s commitment to the development of shared resources that facilitate interdisciplinary research through numerous Core facilities that service both laboratory and clinical research programs.

Dr. McRae is Associate Director of Specialty Programs and Diversity in the Office of Academic Training and Outreach Programs. She works to enhance and support CHOP’s growing population of diverse scientists by developing relevant programming and creating an inclusive and welcoming environment for researchers from all backgrounds.

Oversees three departments committed to the health and safety of Research Institute staff and serves as the Institutional Biosafety Officer.

Ensuring Children's Hospital of Philadelphia Research Institute is the industry leader in the use of data and technology to solve challenging problems in child health.

Kristen Pidgeon facilitates the administration of the Intellectual and Developmental Disabilities Research Center’s activities in close collaboration with the Center’s directors and associate directors.

Identifying research programs with unique commercial potential, and helping to create and support strategies to further develop, partner, or prepare these assets for commercialization (license or spin-out).

Amy Salovin, assistant director, Office of Faculty Development, builds strong programs and resources that promote academic success. She is committed to supporting the career progression of research investigators at all levels.

Relies on extensive experience in leadership positions in institution, independent, and governmental Institutional Review Boards to support investigators while they navigate multicenter research studies.

Dan Singleton delivers actionable clinical data to researchers and provides tools for efficient data management and reconciling data capture in the clinical domain with secondary use for research purposes.

Dr. Spatz is an internationally recognized researcher, clinician, and educator in the field of human milk and breastfeeding, particularly in vulnerable populations. Her research directly changes clinical practice to improve human milk and breastfeeding outcomes in the United States and globally.

Abbie Suberman leads a team that develops and integrates research strategies and priorities into clinical and operational domains.

Promoting collaboration between academia and industry by developing relationships with other institutions, biotechnology, pharmaceutical, and medical device companies to continue research and to commercialize CHOP research discoveries and technology-based ventures.

Oversees the daily operations that provide financial accounting support for externally funded as well as internally funded awards and contracts.

Advances CHOP’s education and research missions by working collaboratively to create a culture of learning, discovery, integrity, and innovation to ensure success of the next generation of scientific leaders in child health.

Building upon Children’s Hospital of Philadelphia’s legacy as one of the preeminent pediatric research institutions in the world, Bryan Wolf, MD, PhD, served as Executive Vice President and Chief Scientific Officer from 2015 to June 1, 2021, overseeing implementation of an ambitious, faculty-led strategic plan to make the most of the Research Institute’s unique resources, infrastructure, intellect, and talent to conduct transformational research initiatives with the highest scientific integrity from bench to bedside.

Dr. Ackermann studies diabetes (types 1 and 2) and congenital hyperinsulinism using mouse models, cell lines, and primary human tissue. She aims to identify novel pathways regulating beta cell insulin secretion, leading to innovative therapeutic strategies for these disorders. Current studies include in vivo mouse physiology, ex vivo human islet physiology, CRISPR-Cas9 gene editing, epigenetic modification, and single-cell functional genomics.

Dr. Adams is director of the Comprehensive Vascular Anomalies Program, a cutting-edge, multidisciplinary program that seeks breakthrough treatments and cures for children, adolescents, and young adults with rare, life-threatening tumors and malformations. 

The founder and director of CHOP's Center for Fetal Diagnosis and Treatment, Dr. Adzick is an innovator in the field of fetal medicine, pursuing groundbreaking prenatal treatment for debilitating birth defects. He led the NIH-funded "Management of Myelomeningocele Study" (MOMS) at CHOP, a breakthrough research program that showed fetal surgery for spina bifida results in significantly improved outcomes.

Dr. Afolabi-Brown's research centers on determining the role of polysomnography in facilitating tracheostomy decannulation in children.

Dr. Ahrens-Nicklas works to understand why patients with inherited biochemical disorders often suffer severe, untreatable neurologic and cardiac symptoms. She strives to elucidate the link between biochemistry and network excitability, in order to drive new approaches to therapy.

Dr. Akers is an adolescent gynecologist and her research focuses on improving reproductive health outcomes among adolescent women by reducing teen pregnancy, and reducing sexually transmitted infection rates by increasing adolescents’ access to high quality reproductive health services.

Dr. Akizu's research focuses on cerebellar ataxias and motoneuron disorders, with the specific goals of uncovering the particularities of these neuronal types, understanding disease mechanisms, and exploring treatment options.